EKF Diagnostics (LON:EKF) Trading Up 12.3% – Here’s What Happened

Shares of EKF Diagnostics Holdings plc (LON:EKF) rose 12.3% on Tuesday . The stock traded as high as GBX 23.77 ($0.31) and last traded at GBX 23.02 ($0.30). Approximately 3,099,554 shares traded hands during mid-day trading, an increase of 555% from the average daily volume of 473,495 shares. The stock had previously closed at GBX 20.50 ($0.26).

EKF Diagnostics Trading Down 3.6 %

The company has a quick ratio of 1.77, a current ratio of 4.60 and a debt-to-equity ratio of 0.34. The firm has a market capitalization of £94.23 million, a P/E ratio of 19.73 and a beta of 0.57. The firm’s 50-day simple moving average is GBX 23.23 and its 200-day simple moving average is GBX 25.85.

EKF Diagnostics (LON:EKF) last posted its quarterly earnings data on Tuesday, March 25th. The company reported GBX 1.38 ($0.02) earnings per share (EPS) for the quarter. EKF Diagnostics had a net margin of 9.37% and a return on equity of 7.03%. Analysts anticipate that EKF Diagnostics Holdings plc will post 2.2987842 EPS for the current year.

Insider Activity

In other EKF Diagnostics news, insider Gavin T. Jones bought 50,000 shares of EKF Diagnostics stock in a transaction that occurred on Tuesday, March 25th. The shares were bought at an average price of GBX 22 ($0.28) per share, with a total value of £11,000 ($14,162.48). Corporate insiders own 5.24% of the company’s stock.

EKF Diagnostics Company Profile

EKF is an AIM-listed global diagnostics business focussed on:

● Point-of-Care analysers in the key areas of Hematology and Diabetes

● Life Sciences services provide specialist manufacture of enzymes and custom products for use in diagnostic, food and industrial applications.

EKF has headquarters in Penarth (near Cardiff) and operates five manufacturing sites across the US and Germany, selling into over 120 countries world-wide.